½ÃÀ庸°í¼­
»óǰÄÚµå
1585797

³ú ÀÓÇöõÆ® ½ÃÀå : À¯Çü, Àç·á, ÀûÀÀÁõ, ÃÖÁ¾ »ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Brain Implants Market by Type (Bioresorbable Implants, Deep Brain Stimulators, Vagus Nerve Stimulators), Material (Platinum-Iridium, Stainless Steel, Tungsten), Indication, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 187 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

³ú ÀÓÇöõÆ® ½ÃÀå 2023³â ½ÃÀå ±Ô¸ð´Â 17¾ï 2,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 18¾ï 6,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 9.88%·Î ¼ºÀåÀ» Áö¼ÓÇÏ¿© 2030³â¿¡´Â 33¾ï 3,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

³ú ÀÓÇöõÆ® ½ÃÀåÀº ½Å°æ ¿¬°áÀ» È®¸³ÇÏ°í ½Å°æ ÁúȯÀÇ Ä¡·á ¹× ½Å°æ ±â´É °­È­¸¦ ÃËÁøÇϱâ À§ÇØ ³ú Á¶Á÷¿¡ À̽ÄÇÏ´Â ÀÇ·á±â±â¿¡ ÁßÁ¡À» µÐ °ÍÀ¸·Î Á¤Àǵ˴ϴÙ. ³ú ÀÓÇöõÆ®ÀÇ Çʿ伺Àº Àü ¼¼°è Àα¸ÀÇ °í·ÉÈ­¿Í ÆÄŲ½¼º´, ¾ËÃ÷ÇÏÀ̸Ӻ´, °£Áú°ú °°Àº ½Å°æ ÅðÇ༺ ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ ´ëµÎµÇ°í ÀÖ½À´Ï´Ù. Ä¡·áºÎÅÍ ÀÎÁö ±â´É Çâ»ó, ÷´Ü º¸Á¶±â±¸¿¡ À̸£±â±îÁö ´Ù¾çÇÑ ¿ëµµ·Î »ç¿ëµÇ¸ç, ÁÖ¿ä ÃÖÁ¾ »ç¿ëÀÚ´Â ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü, ¿¬±¸ ±â°ü, ÀÎÁö ±â´É °³¼±À» ¿øÇÏ´Â °³ÀÎÀÔ´Ï´Ù. ÀÌ ½ÃÀåÀº ½Å°æ±â¼úÀÇ ¹ßÀü, R&D ÅõÀÚ Áõ°¡, °³ÀÎ ¸ÂÃãÇü ÀÇ·á °³ÀÔ¿¡ ´ëÇÑ °ü½É Áõ°¡ µîÀÇ ¿µÇâÀ» ¹Þ¾Æ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÃÖ±Ù »ýü Àç·á¿Í ¼ÒÇüÈ­ÀÇ ¹ßÀüÀº ´õ °¡º±°í È¿À²ÀûÀ̸ç, ´õ ±¤¹üÀ§ÇÑ ½Å°æ ÁúȯÀ» Ä¡·áÇÒ ¼ö ÀÖ´Â µð¹ÙÀ̽ºÀÇ °¡´É¼ºÀ» ¿­¾îÁÖ¸ç Çõ½ÅÀÇ Å« ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±×·¯³ª ÀÌ·¯ÇÑ ±âȸ´Â À±¸®Àû µô·¹¸¶, ³ôÀº R&D ºñ¿ë, ±î´Ù·Î¿î ±ÔÁ¦ À庮°ú °°Àº °úÁ¦¿Í ÇÔ²² ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã¿Í º¸¾È¿¡ ´ëÇÑ ¿ì·Á´Â »óȲÀ» ´õ¿í º¹ÀâÇÏ°Ô ¸¸µé°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇØ ±â¾÷µéÀº ±ÔÁ¦ ±â°ü°úÀÇ Çù·Â °ü°è¸¦ ±¸ÃàÇϰí, ¾ÈÀü¼º°ú À¯È¿¼ºÀ» ¿ì¼±½ÃÇÏ´Â »ç¿ëÀÚ Áß½ÉÀÇ ÀÓÇöõÆ® ¼³°è¿¡ ÅõÀÚÇÏ´Â °ÍÀÌ ÇʼöÀûÀÔ´Ï´Ù. ƯÈ÷ ºñħ½ÀÀû Áø´Ü µµ±¸¿Í ´Ù±â´É ÀÓÇöõÆ® °³¹ßÀº Å« ÁøÀüÀ» ÀÌ·ê ¼ö ÀÖ½À´Ï´Ù. ÀΰøÁö´É ¹× ¸Ó½Å·¯´×°úÀÇ ÅëÇÕÀ» ÅëÇØ ³ú ÀÓÇöõÆ®ÀÇ ±â´É¼º°ú °á°ú¸¦ Çâ»ó½ÃŰ´Â Ãß¼¼·Î ÀÎÇØ ½ÃÀåÀº °è¼Ó ÁøÈ­ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¿ªµ¿ÀûÀÎ ½ÃÀå ȯ°æÀº »õ·Î¿î ±â¼úÀ» Ȱ¿ëÇϱâ À§ÇÑ Áö¼ÓÀûÀÎ Çõ½Å°ú Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ¿ä±¸Çϰí ÀÖÀ¸¸ç, À±¸®ÀûÀÎ ¹®Á¦¸¦ ÇØ°áÇϰí ÄÄÇöóÀ̾𽺸¦ º¸ÀåÇÏ´Â µ¿½Ã¿¡ »õ·Î¿î ±â¼úÀ» Ȱ¿ëÇϱâ À§ÇÑ ³ë·ÂÀÌ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÑ »óȲÀ» Àß ÇìÃijª°¡´Â °ÍÀÌ ³ú ÀÓÇöõÆ® ºÐ¾ß¿¡¼­ Áö¼ÓÀûÀÎ ¼ºÀåÀ» ÀÌ·ç±â À§ÇØ ÇʼöÀûÀÔ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 17¾ï 2,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 18¾ï 6,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 33¾ï 3,000¸¸ ´Þ·¯
CAGR(%) 9.88%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ³ú ÀÓÇöõÆ® ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

³ú ÀÓÇöõÆ® ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Àα¸ÀÇ ½Å°æ Áúȯ À¯º´·ü Áõ°¡
    • ÃÖ¼Òħ½À ¼ö¼úÀÇ Ã¤Åà Áõ°¡
    • ½Å°æÁúȯÀÇ Á¶±â Áø´Ü°ú Ä¡·á¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ³ú ÀÓÇöõÆ® Á¦Ç° ¹× ¼ö¼ú ºñ¿ëÀÇ ±Þ»ó½Â
  • ½ÃÀå ±âȸ
    • ÷´Ü ½ÅÁ¦Ç° °³¹ß Áõ°¡
    • ÷´Ü ÀÇ·á ½Ã¼³¿¡ ´ëÇÑ ÅõÀÚ ¹× ÀÌ´Ï¼ÅÆ¼ºê Áõ°¡
  • ½ÃÀå °úÁ¦
    • ½Å°æ¿Ü°ú ¼ö¼ú¿¡ µû¸¥ À§Çè°ú ÇÕº´Áõ

Portre's Five Forces: ³ú ÀÓÇöõÆ® ½ÃÀå °ø·«À» À§ÇÑ Àü·«Àû µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ³ú ÀÓÇöõÆ® ½ÃÀå¿¡¼­ÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ³ú ÀÓÇöõÆ® ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ³ú ÀÓÇöõÆ® ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

³ú ÀÓÇöõÆ® ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ³ú ÀÓÇöõÆ® ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ³ú ÀÓÇöõÆ® ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

³ú ÀÓÇöõÆ® ½ÃÀå¿¡¼­ÀÇ ¼º°øÀ» À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

³ú ÀÓÇöõÆ® ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚµéÀÌ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ µµ¿òÀÌ µÇ´Â Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ³ú ÀÓÇöõÆ® ½ÃÀå : À¯Çüº°

  • »ýüÈí¼ö¼º ÀÓÇöõÆ®
  • ³ú½ÉºÎ ÀÚ±Ø ±â±â
  • ¹ÌÁֽŰæ ÀÚ±Ø ±â±â

Á¦7Àå ³ú ÀÓÇöõÆ® ½ÃÀå : ¼ÒÀ纰

  • Ç÷¡Æ¼³Ñ À̸®µã
  • ½ºÅ×Àθ®½º ½ºÆ¿
  • ÅÖ½ºÅÙ

Á¦8Àå ³ú ÀÓÇöõÆ® ½ÃÀå : ÀûÀÀÁõº°

  • ¾ËÃ÷ÇÏÀ̸Ӻ´
  • ¸¸¼º ÅëÁõ
  • °£Áú
  • ÆÄŲ½¼º´

Á¦9Àå ³ú ÀÓÇöõÆ® ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø
  • ½Å°æ°ú Ŭ¸®´Ð

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ³ú ÀÓÇöõÆ® ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ³ú ÀÓÇöõÆ® ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ³ú ÀÓÇöõÆ® ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • Beijing Pins Medical Co., Ltd.
  • Boston Scientific Corporation
  • Cochlear Limited
  • CorTec GmbH
  • DBS Technologies Pty Ltd
  • Fisher Wallace
  • Functional Neuromodulation, Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • MicroTransponder Inc.
  • Nalu Medical, Inc.
  • NeuroPace Inc.
  • NeuroSigma, Inc.
  • Nevro Corporation
  • Nexstim Oyj
  • Paradromics Inc.
  • Precision Neuroscience
  • Renishaw PLC
  • SceneRay Co., Ltd.
  • SetPoint Medical
  • Synapse Biomedical Inc.
  • Synchron
  • Thermo Fisher Scientific Inc.
LSH 24.11.13

The Brain Implants Market was valued at USD 1.72 billion in 2023, expected to reach USD 1.86 billion in 2024, and is projected to grow at a CAGR of 9.88%, to USD 3.33 billion by 2030.

The brain implant market is defined by its focus on medical devices implanted in brain tissues to establish neural connections, facilitating treatment for neurological disorders and enhancement of neural functions. The necessity for brain implants is driven by an aging global population and the rising prevalence of neurodegenerative diseases such as Parkinson's, Alzheimer's, and epilepsy. Applications range from medical treatment to cognitive enhancement and advanced prosthetics, with primary end-users being healthcare providers, research institutions, and individuals seeking cognitive performance improvement. The market is witnessing growth influenced by advances in neural technology, increasing investment in R&D, and a stronger emphasis on personalized medical interventions. Recent advances in biomaterials and miniaturization have opened potential opportunities for lighter, more efficient devices that cater to a broader range of neurological conditions, offering substantial opportunities for innovation. However, these opportunities come alongside challenges such as ethical dilemmas, high R&D costs, and stringent regulatory hurdles which can impede market growth. Additionally, concerns over data privacy and security further complicate the landscape. To address these challenges, it is essential for businesses to foster collaborations with regulatory bodies and invest in user-centric implant designs that prioritize safety and efficacy. Innovation in non-invasive and hybrid technologies presents untapped potential; specifically, developing non-invasive diagnostic tools and multifunctional implants can lead to significant advancements. The market is expected to continue evolving, with trends towards integration with artificial intelligence and machine learning to enhance the functionality and outcomes of brain implants. This dynamic market environment calls for continuous innovations and strategic partnerships to capitalize on emerging technologies while ensuring compliance and addressing ethical concerns. The successful navigation of these complexities will be critical to achieving sustainable growth in the brain implant sector.

KEY MARKET STATISTICS
Base Year [2023] USD 1.72 billion
Estimated Year [2024] USD 1.86 billion
Forecast Year [2030] USD 3.33 billion
CAGR (%) 9.88%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Brain Implants Market

The Brain Implants Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of neurological disorders among population
    • Rising adoption of minimally invasive surgery
    • Awareness towards early diagnosis and treatments of neurological treatments
  • Market Restraints
    • High cost of brain implant products and surgeries
  • Market Opportunities
    • Growing rate of advanced new product development
    • Rising investments and initiatives towards advance healthcare facilities
  • Market Challenges
    • Risk and complications associated with neuro surgeries

Porter's Five Forces: A Strategic Tool for Navigating the Brain Implants Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Brain Implants Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Brain Implants Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Brain Implants Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Brain Implants Market

A detailed market share analysis in the Brain Implants Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Brain Implants Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Brain Implants Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Brain Implants Market

A strategic analysis of the Brain Implants Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Brain Implants Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aleva Neurotherapeutics SA, Beijing Pins Medical Co., Ltd., Boston Scientific Corporation, Cochlear Limited, CorTec GmbH, DBS Technologies Pty Ltd, Fisher Wallace, Functional Neuromodulation, Ltd., LivaNova PLC, Medtronic PLC, MicroTransponder Inc., Nalu Medical, Inc., NeuroPace Inc., NeuroSigma, Inc., Nevro Corporation, Nexstim Oyj, Paradromics Inc., Precision Neuroscience, Renishaw PLC, SceneRay Co., Ltd., SetPoint Medical, Synapse Biomedical Inc., Synchron, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Brain Implants Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Bioresorbable Implants, Deep Brain Stimulators, and Vagus Nerve Stimulators.
  • Based on Material, market is studied across Platinum-Iridium, Stainless Steel, and Tungsten.
  • Based on Indication, market is studied across Alzheimer's Disease, Chronic Pain, Epilepsy, and Parkinson's Disease.
  • Based on End-User, market is studied across Hospitals and Neurology Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of neurological disorders among population
      • 5.1.1.2. Rising adoption of minimally invasive surgery
      • 5.1.1.3. Awareness towards early diagnosis and treatments of neurological treatments
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of brain implant products and surgeries
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing rate of advanced new product development
      • 5.1.3.2. Rising investments and initiatives towards advance healthcare facilities
    • 5.1.4. Challenges
      • 5.1.4.1. Risk and complications associated with neuro surgeries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Brain Implants Market, by Type

  • 6.1. Introduction
  • 6.2. Bioresorbable Implants
  • 6.3. Deep Brain Stimulators
  • 6.4. Vagus Nerve Stimulators

7. Brain Implants Market, by Material

  • 7.1. Introduction
  • 7.2. Platinum-Iridium
  • 7.3. Stainless Steel
  • 7.4. Tungsten

8. Brain Implants Market, by Indication

  • 8.1. Introduction
  • 8.2. Alzheimer's Disease
  • 8.3. Chronic Pain
  • 8.4. Epilepsy
  • 8.5. Parkinson's Disease

9. Brain Implants Market, by End-User

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Neurology Clinics

10. Americas Brain Implants Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Brain Implants Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Brain Implants Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Aleva Neurotherapeutics SA
  • 3. Beijing Pins Medical Co., Ltd.
  • 4. Boston Scientific Corporation
  • 5. Cochlear Limited
  • 6. CorTec GmbH
  • 7. DBS Technologies Pty Ltd
  • 8. Fisher Wallace
  • 9. Functional Neuromodulation, Ltd.
  • 10. LivaNova PLC
  • 11. Medtronic PLC
  • 12. MicroTransponder Inc.
  • 13. Nalu Medical, Inc.
  • 14. NeuroPace Inc.
  • 15. NeuroSigma, Inc.
  • 16. Nevro Corporation
  • 17. Nexstim Oyj
  • 18. Paradromics Inc.
  • 19. Precision Neuroscience
  • 20. Renishaw PLC
  • 21. SceneRay Co., Ltd.
  • 22. SetPoint Medical
  • 23. Synapse Biomedical Inc.
  • 24. Synchron
  • 25. Thermo Fisher Scientific Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦